<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40627314</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1868-4297</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cardiovascular intervention and therapeutics</Title><ISOAbbreviation>Cardiovasc Interv Ther</ISOAbbreviation></Journal><ArticleTitle>Five-year outcomes after surgical versus transcatheter aortic valve replacement with new generation devices from the prospective OBSERVANT studies.</ArticleTitle><Pagination><StartPage>943</StartPage><EndPage>953</EndPage><MedlinePgn>943-953</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12928-025-01155-0</ELocationID><Abstract><AbstractText>The efficacy and durability of transcatheter (TAVR) over surgical aortic valve replacement (SAVR) for severe aortic stenosis (AS) has been demonstrated in randomized studies, but these findings were not confirmed in several observational studies. This is an analysis of 5706 AS patients who underwent SAVR from 2010 and 2012, and 2989 AS patients who underwent TAVR from 2017 and 2018 from the prospective OBSERVANT I and II studies. TAVR procedures were performed with new-generation devices. Five-year all-cause mortality was the primary outcome of this analysis. Propensity score matching yielded 1008 pairs of TAVR and SAVR patients. The mean EuroSCORE II was comparable between the study cohorts (TAVR 4.7&#x2009;&#xb1;&#x2009;4.0% and SAVR 4.5&#x2009;&#xb1;&#x2009;5.7%, p&#x2009;=&#x2009;0.419). At 5 years, TAVR was associated with higher mortality (44.4% vs. 33.2%, HR 1.36, 95%CI 1.18-1.57, Log-rank test p&#x2009;&lt;&#x2009;0.001), major adverse cardiac and cerebrovascular events (MACCEs) (49.3% vs. 37.9%, HR 1.32, 95%CI 1.15-1.51, Log-rank test p&#x2009;&lt;&#x2009;0.001), permanent pacemaker implantation (23.1% vs. 9.3%, HR 2.72, 95%CI 2.14-3.45, Log-rank test p&#x2009;&lt;&#x2009;0.001) and percutaneous coronary intervention rates (3.7% vs. 1.2%, HR 3.44, 95%CI 1.76-6.71, Log-rank test p&#x2009;&lt;&#x2009;0.001) compared to SAVR. Age&#x2009;&#x2264;&#x2009;80 years, male gender, EuroSCORE II&#x2009;&#x2264;&#x2009;4.0%, absence of coronary artery disease and absence of diabetes were associated with higher 5-year mortality after TAVR compared to SAVR. TAVR had a significantly higher 5-year mortality than SAVR both in patients with left ventricular ejection fraction&#x2009;&#x2264;&#x2009;50% and&#x2009;&gt;&#x2009;50%. This observational study from prospective data showed that TAVR using new-generation devices was associated with increased rates of all-cause mortality compared to SAVR at 5 years. These findings should be viewed considering the non-randomized nature of this study and may be attributable to the characteristics of patients selected for TAVR, rather than the procedure itself.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosato</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6690-5537</Identifier><AffiliationInfo><Affiliation>National Centre for Global Health, Istituto Superiore Di Sanit&#xe0;, Via Giano Della Bella 34, 00161, Rome, Italy. stefano.rosato@iss.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biancari</LastName><ForeName>Fausto</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Centro Cardiologico Monzino IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbanti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe0; Degli Studi Di Enna "Kore", Enna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantini</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Anesthesia and ICU, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Giuliano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe0; Degli Studi Di Enna "Kore", Enna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe4;kikallio</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, South Karelia Central Hospital, University of Helsinki, Lappeenranta, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ussia</LastName><ForeName>Gian Paolo</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology, Campus Bio-Medico University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baglio</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Italian National Agency for Regional Healthcare Services, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatari</LastName><ForeName>Mahin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Centre for Global Health, Istituto Superiore Di Sanit&#xe0;, Via Giano Della Bella 34, 00161, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistical Sciences, University of Rome "La Sapienza", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badoni</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Centre for Global Health, Istituto Superiore Di Sanit&#xe0;, Via Giano Della Bella 34, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Errigo</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Centre for Global Health, Istituto Superiore Di Sanit&#xe0;, Via Giano Della Bella 34, 00161, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OBSERVANT I. I. Research Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1M30</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>PE-2016-02364619</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Cardiovasc Interv Ther</MedlineTA><NlmUniqueID>101522043</NlmUniqueID><ISSNLinking>1868-4297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="Y">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006350" MajorTopicYN="Y">Heart Valve Prosthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SAVR</Keyword><Keyword MajorTopicYN="N">TAVR</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve implantation</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve replacement</Keyword></KeywordList><CoiStatement>Declarations. Conflicts of interest: Prof. Barbanti is a consultant for Medtronic, Edwards Lifesciences and Boston Scientific. The other authors do not have any conflict of interest to disclose. Institutional review boad: The Ethical Committee of each participating centers granted permission to participate in the OBSERVANT I and II studies. Informed consent: Informed consent was obtained from all subjects involved in the study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40627314</ArticleId><ArticleId IdType="doi">10.1007/s12928-025-01155-0</ArticleId><ArticleId IdType="pii">10.1007/s12928-025-01155-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mack MJ, Leon MB, Thourani VH, Pibarot P, Hahn RT, Genereux P, Kodali SK, Kapadia SR, Cohen DJ, Pocock SJ, Lu M, White R, Szerlip M, Ternacle J, Malaisrie SC, Herrmann HC, Szeto WY, Russo MJ, Babaliaros V, Smith CR, Blanke P, Webb JG, Makkar R. PARTNER 3 Investigators, Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023;389:1949&#x2013;60. https://doi.org/10.1056/NEJMoa2307447 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2307447</ArticleId><ArticleId IdType="pubmed">37874020</ArticleId></ArticleIdList></Reference><Reference><Citation>Thyregod HGH, J&#xf8;rgensen TH, Ihlemann N, Steinbr&#xfc;chel DA, Nissen H, Kjeldsen BJ, Petursson P, De Backer O, Olsen PS, S&#xf8;ndergaard L. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J. 2024;45:1116&#x2013;24. https://doi.org/10.1093/eurheartj/ehae043 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae043</ArticleId><ArticleId IdType="pubmed">38321820</ArticleId><ArticleId IdType="pmc">10984572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M, Ahsan A, Shafiq A, Nadeem ZA, Arif F, Zulfiqar E, Kazmi MH, Yadav R, Jain H, Ahmed R, Alam M, Shahid F. Meta-analysis of longitudinal comparison of transcatheter versus surgical aortic valve replacement in patients at low to intermediate surgical risk. Int J Surg. 2024;110:8097&#x2013;106. https://doi.org/10.1097/JS9.0000000000002158 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JS9.0000000000002158</ArticleId><ArticleId IdType="pubmed">39806748</ArticleId><ArticleId IdType="pmc">11634167</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1; MP, Jacquemyn X, Van den Eynde J, Serna-Gallegos D, Chu D, Clavel MA, Pibarot P, Sultan I. Midterm survival of low-risk patients treated with transcatheter versus surgical aortic valve replacement: meta-analysis of reconstructed time-to-event data. J Am Heart Assoc. 2023;12: e030012. https://doi.org/10.1161/JAHA.123.030012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.123.030012</ArticleId><ArticleId IdType="pubmed">37929669</ArticleId><ArticleId IdType="pmc">10727380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburino C, Barbanti M, D&#x2019;Errigo P, Ranucci M, Onorati F, Covello RD, Santini F, Rosato S, Santoro G, Fusco D, Grossi C, Seccareccia F. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT study. J Am Coll Cardiol. 2015;66:804&#x2013;12. https://doi.org/10.1016/j.jacc.2015.06.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.06.013</ArticleId><ArticleId IdType="pubmed">26271063</ArticleId></ArticleIdList></Reference><Reference><Citation>Seccareccia F, Tarantini G, Bedogni F, Berti S, Santoro G, Tamburino C, Ussia GP, Barbanti M, Baiocchi M, Ranucci M, D&#x2019;Errigo P, Rosato S, Musumeci G. OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol G Ital Cardiol. 2017;18(6 Suppl 1):14S-26S. https://doi.org/10.1714/2718.27731 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1714/2718.27731</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2013;9. https://doi.org/10.1016/j.jclinepi.2007.11.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Stadnyk K, MacKnight C, McDowell I, H&#xe9;bert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205&#x2013;6. https://doi.org/10.1016/S0140-6736(98)04402-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)04402-X</ArticleId><ArticleId IdType="pubmed">9923878</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734&#x2013;44. https://doi.org/10.1093/ejcts/ezs043 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezs043</ArticleId><ArticleId IdType="pubmed">22378855</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter C. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150&#x2013;61. https://doi.org/10.1002/pst.433 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.433</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, Bleiziffer S, Borger MA, Choi YH, Clemmensen P, Cremer J, Czerny M, Diercks N, Eitel I, Ensminger S, Frank D, Frey N, Hagendorff A, Hagl C, Hamm C, Kappert U, Karck M, Kim WK, K&#xf6;nig IR, Krane M, Landmesser U, Linke A, Maier LS, Massberg S, Neumann FJ, Reichenspurner H, Rudolph TK, Schmid C, Thiele H, Twerenbold R, Walther T, Westermann D, Xhepa E, Ziegler A, Falk V. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med. 2024;390:1572&#x2013;83. https://doi.org/10.1056/NEJMoa2400685 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2400685</ArticleId><ArticleId IdType="pubmed">38588025</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancari F, M&#xe4;kikallio T, D&#x2019;Errigo P, Polvani G. Value of observational studies in the outcome evaluation of transcatheter and surgical aortic valve replacement. Interdiscip Cardiovasc Thorac Surg. 2024;39:ivae198. https://doi.org/10.1093/icvts/ivae198 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivae198</ArticleId><ArticleId IdType="pubmed">39607784</ArticleId><ArticleId IdType="pmc">11660568</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasniqi L, Brandes A, Mortensen PE, Gerke O, Riber L. Severe aortic stenosis treated with transcatheter aortic valve implantation or surgical aortic valve replacement with Perimount in Western Denmark 2016&#x2013;2022: a nationwide retrospective study. Interdiscip Cardiovasc Thorac Surg. 2024;39:ivae122. https://doi.org/10.1093/icvts/ivae122 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivae122</ArticleId><ArticleId IdType="pubmed">38944031</ArticleId><ArticleId IdType="pmc">11229432</ArticleId></ArticleIdList></Reference><Reference><Citation>Barili F, Brophy JM, Ronco D, Myers PO, Uva MS, Almeida RMS, Marin-Cuartas M, Anselmi A, Tomasi J, Verhoye JP, Musumeci F, Mandrola J, Kaul S, Papatheodorou S, Parolari A. Risk of bias in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: a systematic review and meta-analysis. JAMA Netw Open. 2023;6: e2249321. https://doi.org/10.1001/jamanetworkopen.2022.49321 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.49321</ArticleId><ArticleId IdType="pubmed">36595294</ArticleId><ArticleId IdType="pmc">9857525</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancari F, D&#x2019;Errigo P, Barbanti M, Badoni G, Tamburino C, Polvani G, Costa G, Baglio G, Rosato S. Ten-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients: The OBSERVANT study. Int J Cardiol Heart Vasc. 2024;55: 101545. https://doi.org/10.1016/j.ijcha.2024.101545 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2024.101545</ArticleId><ArticleId IdType="pubmed">39555490</ArticleId><ArticleId IdType="pmc">11567919</ArticleId></ArticleIdList></Reference><Reference><Citation>Moawad KR, Mohamed S, Hammad A, Barker T. The clinical impact of paravalvular leaks with transcutaneous aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR): A systematic review and meta-Analysis. Heart Lung Circ. 2024;33:1319&#x2013;30. https://doi.org/10.1016/j.hlc.2024.02.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2024.02.017</ArticleId><ArticleId IdType="pubmed">38839468</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1; MP, Jacquemyn X, Van den Eynde J, Tasoudis P, Erten O, Sicouri S, Macedo FY, Pasala T, Kaple R, Weymann A, Ruhparwar A, Clavel MA, Pibarot P, Ramlawi B. Impact of paravalvular leak on outcomes after transcatheter aortic valve implantation: meta-Analysis of Kaplan-Meier-derived individual patient data. Struct Heart. 2022;7: 100118. https://doi.org/10.1016/j.shj.2022.100118 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.shj.2022.100118</ArticleId><ArticleId IdType="pubmed">37275584</ArticleId><ArticleId IdType="pmc">10236885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando T, Briasoulis A, Telila T, Afonso L, Grines CL, Takagi H. Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis Catheter Cardiovasc Interv. 2018;91:135&#x2013;47. https://doi.org/10.1002/ccd.27336 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27336</ArticleId><ArticleId IdType="pubmed">28963761</ArticleId></ArticleIdList></Reference><Reference><Citation>Laakso T, Laine M, Moriyama N, Dahlbacka S, Airaksinen J, Virtanen M, Husso A, Tauriainen T, Niemel&#xe4; M, M&#xe4;kikallio T, Valtola A, Eskola M, Juvonen T, Biancari F, Raivio P. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement. Eur J Cardiothorac Surg. 2020;58:1145&#x2013;52. https://doi.org/10.1093/ejcts/ezaa254 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezaa254</ArticleId><ArticleId IdType="pubmed">33057657</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, Liu T, Liang J, Zhou YJ, Liu W. Impact of postprocedural permanent pacemaker implantation on clinical outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis. J Thorac Dis. 2019;11:5130&#x2013;9. https://doi.org/10.21037/jtd.2019.12.02 .</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2019.12.02</ArticleId><ArticleId IdType="pubmed">32030230</ArticleId><ArticleId IdType="pmc">6987986</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Zhang E, Qian Z, Sun J, Zou F, Wang Y, Hou X, Zou J. Mid- to long-term clinical and echocardiographic effects of post-procedural permanent pacemaker implantation after transcatheter aortic valve replacement: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;28(9): 911234. https://doi.org/10.3389/fcvm.2022.911234 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.911234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. Canada Med Ass J. 2005;173(5):489&#x2013;95. https://doi.org/10.1503/cmaj.050051 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancari F, Valtola A, Juvonen T, Husso A, Dahlbacka S, Laakso T, Jalava MP, Tauriainen T, Ahvenvaara T, Kinnunen EM, Niemel&#xe4; M, M&#xe4;kikallio T, Eskola M, Virtanen MPO, Maaranen P, Rosato S, Anttila V, Vento A, Airaksinen J, Raivio P. Trifecta versus Perimount Magna Ease aortic valve prostheses. Ann Thorac Surg. 2020;110:879&#x2013;88. https://doi.org/10.1016/j.athoracsur.2019.12.071 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2019.12.071</ArticleId><ArticleId IdType="pubmed">32061588</ArticleId></ArticleIdList></Reference><Reference><Citation>Issa IF, Poulsen SH, Waziri F, Torp Pedersen C, Nielsen PH, Riber L, Dahl JS, S&#xf8;gaard P, N&#xf8;rgaard MA, M&#xf8;ller JE. Structural valve deterioration in the Mitroflow biological heart valve prosthesis. Eur J Cardiothorac Surg. 2018;53:136&#x2013;42. https://doi.org/10.1093/ejcts/ezx321 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezx321</ArticleId><ArticleId IdType="pubmed">29029140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>